| 000 | 01507 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515023011.0 | ||
| 264 | 0 | _c20060525 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEttlinger, Dagmar E | |
| 245 | 0 | 0 |
_aIn vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a1337-41 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacokinetics |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aCamptothecin _xadministration & dosage |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xblood |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucuronides _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIrinotecan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProdrugs _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aMitterhauser, Markus | |
| 700 | 1 | _aWadsak, Wolfgang | |
| 700 | 1 | _aOstermann, Eva | |
| 700 | 1 | _aFarkouh, André | |
| 700 | 1 | _aSchueller, Johann | |
| 700 | 1 | _aCzejka, Martin | |
| 773 | 0 |
_tAnticancer research _gvol. 26 _gno. 2B _gp. 1337-41 |
|
| 999 |
_c16224239 _d16224239 |
||